thyroid cancer and glp-1 Current human data do not show a link between receptor agonist medications the most common types of cancer, according to a a white paper issued by the Clayman Thyroid GLP-1 Medications & Thyroid Cancer

Zhang J, Qiao W, Luo Y

Patients mix these up constantly, so heres the short version

Compound Information Technical Specifications Sources & References Peer-Reviewed Research All research metrics sourced from published peer-reviewed studies New England Journal of Medicine 2023 Retatrutide, a GIP, GLP-1, and glucagon receptor agonist Phase 2 weight loss trial View Source NEJM 2017 Semaglutide and cardiovascular outcomes in patients with type 2 diabetes View Source Cell Metabolism 2020 GIP and GLP-1 receptor co-agonism metabolic synergy mechanisms View Source Nature 2022 The molecular basis of GLP-1R / GIPR co-agonism for weight management View Source For Research Use Only Important Notice This product is sold strictly for research, laboratory, and educational purposes only

I cant recommend Izadora enough